Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Jul-17 9:36 PM View:  | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 20-Jul-17 | Market Sale | 23,445 | $10.50 | $246,172.00 | (< 1%) 2.42M to 2.4M | 86% |
| 21-Jul-17 9:36 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 19-Jul-17 | Market Sale | 20,786 | $10.50 | $218,253.00 | (< 1%) 2.44M to 2.42M | 86% |
| 18-Jul-17 9:03 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 18-Jul-17 | Market Sale | 1,339 | $10.50 | $14,059.50 | (< 1%) 2.44M to 2.44M | 86% |
| 18-Jul-17 9:03 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 17-Jul-17 | Market Sale | 47,460 | $10.50 | $498,415.00 | (2%) 2.49M to 2.44M | 86% |
| 18-Jul-17 9:03 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 14-Jul-17 | Market Sale | 21,055 | $10.53 | $221,789.00 | (< 1%) 2.51M to 2.49M | 86% |
| 13-Jul-17 9:22 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 13-Jul-17 | Market Sale | 39,914 | $10.54 | $420,757.00 | (2%) 2.55M to 2.51M | 86% |
| 13-Jul-17 9:22 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 12-Jul-17 | Market Sale | 13,740 | $10.50 | $144,271.00 | (< 1%) 2.57M to 2.55M | 86% |
| 13-Jul-17 9:22 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 11-Jul-17 | Market Sale | 3,521 | $10.52 | $37,027.20 | (< 1%) 2.57M to 2.57M | 86% |
| 07-Jul-17 9:29 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 07-Jul-17 | Market Sale | 133 | $10.50 | $1,396.50 | (< 1%) 2.57M to 2.57M | 86% |
| 07-Jul-17 9:29 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 05-Jul-17 | Market Sale | 2,562 | $10.52 | $26,960.40 | (< 1%) 2.57M to 2.57M | 86% |
| 27-Jun-17 9:54 PM View: | Seltzer Elyse G. Chief Medical Officer | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 2,400 | -- | -- | 100% 0 to 2.4K | |
| 27-Jun-17 9:56 PM View: | Khuong Chau Quang Director 10% Owner | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 3,919,600 | -- | -- | 100% 0 to 3.92M | |
| 27-Jun-17 9:53 PM View: | Broom Colin Md Chief Executive Officer Director | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 1,595 | -- | -- | 100% 0 to 1.59K | |
| 27-Jun-17 9:54 PM View: | Talbot George Harrison Director | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 31,790 | -- | -- | 100% 0 to 31.79K | |
| 28-Jun-17 6:01 AM View: | Sender Gary Chief Financial Officer | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 2,200 | -- | -- | 100% 0 to 2.2K | |
| 27-Jun-17 9:53 PM View: | Broom Colin Md Chief Executive Officer Director | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 155,817 | -- | -- | 9769% 1.59K to 157.41K | |
| 27-Jun-17 9:55 PM View: | Gelone Steven P. Chief Development Officer | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 12,740 | -- | -- | 100% 0 to 12.74K |
